Companies are struggling to find and retain data analytics talent. Find out why there's a shortage of data analysts and what ...

SAN FRANCISCO and VANCOUVER, British Columbia, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“the Company” or “Jade”), (Nasdaq: ...

The consulting industry thrives on trust. Clients hire firms based on their reputation for expertise, integrity, and ...

SAN FRANCISCO and VANCOUVER, British Columbia, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. ('the Company” or 'Jade”), (Nasdaq: JBIO), a clinical-stage biotechnology company focused on ...

At Celosphere 2025 in Munich, the German telco demonstrated how combining process mining with predictive AI enabled proactive customer interventions - offering a practical blueprint for ...

Otovo AS Class A ( (DE:89K) ) has issued an announcement. Otovo has announced a live-streamed presentation by CEO Andreas Thorsheim on November 6, 2025, at 08:30 CET. This event is part of Otovo’s ...

Comparable long-term effectiveness to standard of care corticosteroids over 5 years Normal growth maintained, in contrast to growth suppression commonly seen with standard of care corticosteroids ...

Presented data underscore the potential of lasme-cel (UCART22) and eti-cel (UCART20x22) to improve outcomes in r/r B-ALL and r/r NHL:Lasme-cel in ...

Allogene Therapeutics, Inc. downgraded to Hold after ALPHA3 trial setbacks. Review updated pipeline prospects and risks.

A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...

Newly released CREModels Lighthouse delivers asset-performance insights to investors and asset-managers in multifamily residential, office, retail, industrial and other sectors. ST. PETERSBURG, Fla., ...